top headlines
Mineralys Therapeutics has reported Phase 3 data showing lorundrostat reduced [...]
SalubrisBio has reported Phase 1b/2 results for its investigational antibody-drug [...]
Movers & Shakers
sponsored content
Personalised cancer medicine is advancing, but better biomarker testing, clinical [...]
AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]
Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]
In this exclusive interview with Liza Laws for Discover Pharma, [...]
Other news
AmplexDiagnostics has launched a CE-IVD molecular diagnostic test that detects [...]
SeaBeLife has secured €2.9 million in French government funding to [...]
Gesynta Pharma has completed recruitment for its Phase 2 trial [...]
Nearly half of surveyed patient groups say they engage with [...]
Kindeva’s global health security division has been awarded a contract [...]
Nabsys has launched RepX, a genomic analysis pipeline designed to [...]
